×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
SESSION 6: HOW TO MONITOR AND PREVENT DILI IN POST AUTHORISATION PHASE
Session Chair(s)
Gaby L. Danan, MD, PhD
Pharmacovigilance Expert
GLD, France
Principles and examples
Speaker(s)
HOW TO MONITOR AND PREVENT DILI IN POST AUTHORISATION PHASE
Gaby L. Danan, MD, PhD
GLD, France
Pharmacovigilance Expert
Have an account?